Free Trial
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel
NASDAQ:AKAN

Akanda Q2 2026 Earnings Results & Report

Akanda logo
$1.80 +0.02 (+0.84%)
As of 09:45 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Akanda reported Q2 2026 earnings on September 30, 2026. The company reported EPS of -$5.90, while revenue was $0.20 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Akanda EPS Results

Actual EPS
-$5.90
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Akanda Revenue Results

Actual Revenue
$0.20 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Akanda Q2 2026 Earnings FAQ

Akanda (NASDAQ:AKAN) reported earnings of -$5.90 per share for Q2 2026. The report was announced on Wednesday, September 30, 2026.

Akanda reported revenue of $0.20 million for Q2 2026.

Akanda Earnings Headlines

Akanda (NASDAQ:AKAN) Stock Lifted to Sell by Wall Street Zen
October 3, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31081441
Akanda (NASDAQ:AKAN) Announces Quarterly Earnings Results
October 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31078690
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
October 9 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Akanda Corp. Reports Earnings Results for the Half Year Ended June 30, 2026
October 1, 2026  |  marketscreener.comM
Akanda Corp. Reports Wider Shareholders’ Deficit in First-Half 2026 Results
September 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/akanda-corp-reports-wider-shareholders-deficit-in-first-half-2026-results?utm_source=marketbeat.com&utm_medium=referral
Akanda Corp. Abandons Cannabis Strategy to Focus on First Towers & Fibers
September 25, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/akanda-corp-abandons-cannabis-strategy-to-focus-on-first-towers-fibers?utm_source=marketbeat.com&utm_medium=referral
See More Akanda Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Akanda? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Akanda and other key companies, straight to your email.

About Akanda

Akanda (NASDAQ:AKAN) is an international medical cannabis company headquartered in London, England. The company has focused on building a supply chain for medical cannabis, including cultivation, processing, importing and distribution, with an emphasis on serving regulated markets.

Akanda’s business has included CanMart, a United Kingdom-based pharmaceutical importer and distributor that supplies medical cannabis products to pharmacies, clinics and patients through the country’s regulated framework. The company has also been associated with Holigen, a Portugal-based cannabis business involved in cultivation and production activities intended to support European medical cannabis markets.

Akanda was established to develop a vertically integrated cannabis platform serving patients and healthcare markets in Europe. Its operations and commercial relationships have primarily centered on the United Kingdom and Portugal, while its publicly traded shares are listed on the Nasdaq under the symbol AKAN.

View Akanda Profile
Earnings Tools